Company Revenue

Orthofix’s Growth Slows as It Struggles to Fill Leadership Roles

Continuing vacancies in key leadership and commercial channel restructuring caused uncertainty and slower sales for Orthofix in 2019....

Feb 26, 2020, Mike Evers

Improving MIS adoption and new products drove NuVasive’s growth in 2019 but the company also announced the launch of its...

Feb 26, 2020, Mike Evers

Despite supply issues in biologics and flat enabling technology sales, Globus had record revenues in 4Q and a third consecutive...

Feb 25, 2020, Mike Evers

Anika has taken steps in its evolution to a global commercial company with the launch of TACTOSET as well as...

Feb 24, 2020, Mike Evers

After struggling with an aging portfolio of sports medicine enabling technology, Smith+Nephew returned that segment to growth leading to a...

Feb 24, 2020, Mike Evers

Integra LifeSciences increased its supply capacity and overhauled its commercial organization in 2019 to accelerate the growth of its orthopedic...

Feb 21, 2020, Mike Evers

Medtronic’s FY3Q20 growth was surprisingly light due to headwinds around Infuse orders, but the enabling technology continues to drive implant...

Feb 19, 2020, Mike Evers

Seikagaku leveraged favorable reimbursement decisions in the U.S. to take share and drive low double-digit growth in FY 3Q19....

Feb 10, 2020, Mike Evers

An aging capital product portfolio and a difficult quarterly comparison caused the ConMed's orthopedics business to backslide in 4Q....

Feb 04, 2020, Mike Evers

Zimmer Biomet mitigated its losses in the U.S. knee market in 4Q19 partially due to the continuing adoption of its...

Feb 04, 2020, Mike Evers

Loading new posts...

No more posts